NCT05045885View on ClinicalTrials.gov

Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 1, 2020

Conditions
COVID-19 PneumoniaExtracorporeal Membrane Oxygenation ComplicationTracheostomy ComplicationRespiratory Failure
Trial Locations (1)

3050

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY